Natural silicate materials, including zeolite clinoptilolite, have been shown to exhibit diverse biological activities and have been used successfully as a vaccine adjuvant and for the treatment of diarrhea. We report a novel use of finely ground clinoptilolite as a potential adjuvant in anticancer therapy. Clinoptilolite treatment of mice and dogs suffering from a variety of tumor types led to improvement in the overall health status, prolongation of life-span, and decrease in tumors size. Local application of clinoptilolite to skin cancers of dogs effectively reduced tumor formation and growth. In addition, toxicology studies on mice and rats demonstrated that the treatment does not have negative effects. In vitro tissue culture studies showed that finely ground clinoptilolite inhibits protein kinase B (c-Akt), induces expression of p21WAF1/CIP1 and p27KIP1 tumor suppressor proteins, and blocks cell growth in several cancer cell lines. These data indicate that clinoptilolite treatment might affect cancer growth by attenuating survival signals and inducing tumor suppressor genes in treated cells.

Crystallization of zeolite ZSM-5 from a diluted heterogeneous system (12.5Na 2 O−Al 2 O 3 −8TPABr−60SiO 2 − 4000H 2 O) was investigated by various experimental methods such as X-ray diffraction (XRD), electron diffraction (ED), infrared spectroscopy (FTIR), X-ray fluorescence (XRF), scanning electron microscopy (SEM), transmission electron microscopy (TEM), atomic force microscopy (AFM), thermo-gravimetric analysis (TGA), particle size analysis (PSA), pH measurement, inductive coupling plasma (ICP) emission spectrometry, and dynamic light scattering (DLS). The crystallization process is characterized by a very long "induction period" (95% of the entire reaction time) and very fast transformation (5% of the entire reaction time) of amorphous to crystalline phase (zeolite ZSM-5) at the end of the crystallization process. Analysis of the obtained results has shown that the crystallization process takes place by a chain of processes: (i) formation of "primary" amorphous aluminosilicate precursor (gel) at room temperature, (ii) formation of "secondary" amorphous aluminosilicate precursor ("worm-like" particles, WLPs) at increased temperature (170 °C), (iii) formation of "tertiary" amorphous aluminosilicate precursor (condensed aggregates, CAs) by aggregation of the WLPs and densification (condensation) of aggregates, and (iv) formation of nuclei and their growth in the matrixes of CAs; these processes result in the formation of fully crystalline zeolite ZSM-5 in the form of polycrystalline aggregates.

No abstract

No abstract

No abstract